A concise review on miRNAs as regulators of colon cancer stem cells and associated signalling pathways

[1]  Sangeetha Rajaram,et al.  Screening of Potential Breast Cancer Inhibitors through Molecular Docking and Molecular Dynamics Simulation , 2022, BioMed research international.

[2]  A. Banerjee,et al.  Tumor suppressor microRNAs in gastrointestinal cancers: A mini-review. , 2022, Recent advances in inflammation & allergy drug discovery.

[3]  A. Bandyopadhyay,et al.  The Emerging Role of MicroRNAs in Bone Diseases and Their Therapeutic Potential , 2021, Molecules.

[4]  Ashutosh Sharma,et al.  Phytochemicals mediated modulation of microRNAs and long non‐coding RNAs in cancer prevention and therapy , 2021, Phytotherapy research : PTR.

[5]  M. Alshahrani,et al.  Current trends and future perspectives of nanomedicine for the management of colon cancer. , 2021, European journal of pharmacology.

[6]  Ashutosh Sharma,et al.  Roles of microRNAs in carbohydrate and lipid metabolism disorders and their therapeutic potential. , 2021, Biochimie.

[7]  F. Slack,et al.  MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic , 2021, Frontiers in Cell and Developmental Biology.

[8]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[9]  M. Matúšková,et al.  Molecular features and gene expression signature of metastatic colorectal cancer , 2021, Oncology reports.

[10]  A. Angius,et al.  Portrait of Cancer Stem Cells on Colorectal Cancer: Molecular Biomarkers, Signaling Pathways and miRNAome , 2021, International journal of molecular sciences.

[11]  B. Boman,et al.  The Role of miRNAs, miRNA Clusters, and isomiRs in Development of Cancer Stem Cell Populations in Colorectal Cancer , 2021, International journal of molecular sciences.

[12]  Z. Dembić.  Antitumor Drugs and Their Targets , 2020, Molecules.

[13]  Wei Zhu,et al.  The effect of miRNA and autophagy on colorectal cancer , 2020, Cell proliferation.

[14]  Tian Li,et al.  MicroRNA: Another Pharmacological Avenue for Colorectal Cancer? , 2020, Frontiers in Cell and Developmental Biology.

[15]  T. Yevsa,et al.  Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies , 2020, Frontiers in Immunology.

[16]  Hiroaki Komuro,et al.  A Comprehensive Review of Cancer MicroRNA Therapeutic Delivery Strategies , 2020, Cancers.

[17]  A. Lam,et al.  The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma , 2020, Cells.

[18]  A. Girigoswami,et al.  A Review on Role of Nanosensors in Detecting Cellular miRNA Expression in Colorectal Cancer. , 2020, Endocrine, metabolic & immune disorders drug targets.

[19]  B. Baradaran,et al.  Colon cancer therapy by focusing on colon cancer stem cells and their tumor microenvironment , 2020, Journal of cellular physiology.

[20]  K. Jeyasubramanian,et al.  BIOCONJUGATED GOLD NANOPARTICLES AS AN EFFICIENT COLORIMETRIC SENSOR FOR CANCER DIAGNOSTICS. , 2020, Photodiagnosis and photodynamic therapy.

[21]  B. Baradaran,et al.  Regulatory mechanisms of microRNAs in colorectal cancer and colorectal cancer stem cells , 2020, Journal of cellular physiology.

[22]  K. Ghaedi,et al.  Signaling pathways involved in colorectal cancer progression , 2019, Cell & Bioscience.

[23]  Jian Huang,et al.  miR-4666-3p and miR-329 Synergistically Suppress the Stemness of Colorectal Cancer Cells via Targeting TGF-β/Smad Pathway , 2019, Front. Oncol..

[24]  Elsa N. Garza Treviño,et al.  Effects of pericytes and colon cancer stem cells in the tumor microenvironment , 2019, Cancer Cell International.

[25]  S. Haan,et al.  Tumor suppressor miR-215 counteracts hypoxia-induced colon cancer stem cell activity. , 2019, Cancer letters.

[26]  Chi-Hung Lin,et al.  Author Correction: MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells , 2019, Nature Cell Biology.

[27]  P. Duijf,et al.  microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities , 2018, Journal of cellular physiology.

[28]  J. Fichna,et al.  One step ahead: miRNA-34 in colon cancer-future diagnostic and therapeutic tool? , 2018, Critical reviews in oncology/hematology.

[29]  M. L. Poeta,et al.  Current understanding and clinical utility of miRNAs regulation of colon cancer stem cells. , 2018, Seminars in cancer biology.

[30]  Irving L. Weissman,et al.  Non-equivalence of Wnt and R-spondin ligands during Lgr5+ intestinal stem cell self-renewal , 2017, Nature.

[31]  Yili Yang,et al.  Reduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling , 2016, Oncotarget.

[32]  Zongguang Zhou,et al.  MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4 , 2016, Oncotarget.

[33]  D. Trisciuoglio,et al.  Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies , 2016, Aging.

[34]  Mulin Liu,et al.  Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine , 2015, Journal of Translational Medicine.

[35]  Özlem Türeci,et al.  mRNA-based therapeutics — developing a new class of drugs , 2014, Nature Reviews Drug Discovery.

[36]  Jian Huang,et al.  The cancer stem cell niche: cross talk between cancer stem cells and their microenvironment , 2014, Tumor Biology.

[37]  Xiling Shen,et al.  A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells. , 2013, Cell stem cell.

[38]  Jinghong Xu,et al.  miRNA-27b Targets Vascular Endothelial Growth Factor C to Inhibit Tumor Progression and Angiogenesis in Colorectal Cancer , 2013, PloS one.

[39]  F. Sarkar,et al.  Down-regulation of miR-21 Induces Differentiation of Chemoresistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens. , 2013, Translational oncology.

[40]  D. M. Pereira,et al.  Delivering the promise of miRNA cancer therapeutics. , 2013, Drug discovery today.

[41]  A. Rustgi,et al.  Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis , 2013, British Journal of Cancer.

[42]  Xi He,et al.  Frizzled and LRP5/6 receptors for Wnt/β-catenin signaling. , 2012, Cold Spring Harbor perspectives in biology.

[43]  S. Kauppinen,et al.  Discovering the first microRNA-targeted drug , 2012, The Journal of cell biology.

[44]  Hui Li,et al.  Interaction between regulatory T cells and cancer stem cells , 2012, International journal of cancer.

[45]  S. Semba,et al.  Mesenchymal Stem Cells Provide an Advantageous Tumor Microenvironment for the Restoration of Cancer Stem Cells , 2012, Pathobiology.

[46]  A. Karnoub,et al.  Mesenchymal stem cells in tumor development , 2012, Cell adhesion & migration.

[47]  B. C. Bernardo,et al.  A microRNA guide for clinicians and basic scientists: background and experimental techniques. , 2012, Heart, lung & circulation.

[48]  Z. Werb,et al.  The extracellular matrix: A dynamic niche in cancer progression , 2012, The Journal of cell biology.

[49]  L. del Vecchio,et al.  Combined CD133/CD44 expression as a prognostic indicator of disease-free survival in patients with colorectal cancer. , 2012, Archives of surgery.

[50]  Serge Battu,et al.  Cancer stem cell sorting from colorectal cancer cell lines by sedimentation field flow fractionation. , 2012, Analytical chemistry.

[51]  Yongzhi Yang,et al.  Elevated oncofoetal miR-17-5p expression regulates colorectal cancer progression by repressing its target gene P130 , 2012, Nature Communications.

[52]  A. Bader,et al.  Developing therapeutic microRNAs for cancer , 2011, Gene Therapy.

[53]  E. Bandrés,et al.  MicroRNA‐451 Is Involved in the Self‐renewal, Tumorigenicity, and Chemoresistance of Colorectal Cancer Stem Cells , 2011, Stem cells.

[54]  E. Kroh,et al.  Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma , 2011, Proceedings of the National Academy of Sciences.

[55]  M. Wong,et al.  The Role of Colorectal Cancer Stem Cells in Metastatic Disease and Therapeutic Response , 2011, Cancers.

[56]  Yanlei Ma,et al.  The relationship between early embryo development and tumourigenesis , 2010, Journal of cellular and molecular medicine.

[57]  C. Croce,et al.  Targeting microRNAs in cancer: rationale, strategies and challenges , 2010, Nature Reviews Drug Discovery.

[58]  Alberto Mantovani,et al.  Macrophages, innate immunity and cancer: balance, tolerance, and diversity. , 2010, Current opinion in immunology.

[59]  A. Ruiz i Altaba,et al.  Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion , 2009, EMBO molecular medicine.

[60]  C. Burge,et al.  Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.

[61]  H. McLeod,et al.  Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo. , 2008, Gastroenterology.

[62]  Michael F. Clarke,et al.  Phenotypic characterization of human colorectal cancer stem cells , 2007, Proceedings of the National Academy of Sciences.

[63]  Linheng Li,et al.  Stem cells and their niche: an inseparable relationship , 2007, Development.

[64]  Xiaoli Ma,et al.  Sonic hedgehog-Gli1 pathway in colorectal adenocarcinomas. , 2007, World journal of gastroenterology.

[65]  C. Ricordi,et al.  Instability of miRNA and cDNAs derivatives in RNA preparations. , 2007, Biochemical and biophysical research communications.

[66]  Y. Akao,et al.  let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. , 2006, Biological & pharmaceutical bulletin.

[67]  A. Oniscu,et al.  Expression of Sonic hedgehog pathway genes is altered in colonic neoplasia , 2004, The Journal of pathology.

[68]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[69]  H. Varmus,et al.  A new nomenclature for int-1 and related genes: The Wnt gene family , 1991, Cell.

[70]  F. Islam,et al.  Natural Compounds Targeting Cancer Stem Cells: A Promising Resource for Chemotherapy. , 2019, Anti-cancer agents in medicinal chemistry.

[71]  A. Misra,et al.  In vivo delivery aspects of miRNA, shRNA and siRNA. , 2012, Critical reviews in therapeutic drug carrier systems.

[72]  Hui Zhang,et al.  Activation of Notch signaling in human colon adenocarcinoma. , 2008, International journal of oncology.